Does INCLISIRAN Cause Low density lipoprotein increased? 423 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 423 reports of Low density lipoprotein increased have been filed in association with INCLISIRAN (LEQVIO). This represents 6.7% of all adverse event reports for INCLISIRAN.
423
Reports of Low density lipoprotein increased with INCLISIRAN
6.7%
of all INCLISIRAN reports
3
Deaths
5
Hospitalizations
How Dangerous Is Low density lipoprotein increased From INCLISIRAN?
Of the 423 reports, 3 (0.7%) resulted in death, 5 (1.2%) required hospitalization, and 9 (2.1%) were considered life-threatening.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INCLISIRAN. However, 423 reports have been filed with the FAERS database.
What Other Side Effects Does INCLISIRAN Cause?
Arthralgia (689)
Myalgia (518)
Injection site pain (488)
Pain in extremity (417)
Pain (342)
Fatigue (325)
Drug ineffective (318)
Diarrhoea (309)
Dyspnoea (297)
Headache (234)
What Other Drugs Cause Low density lipoprotein increased?
EVOLOCUMAB (1,024)
ALIROCUMAB (336)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
LOMITAPIDE (164)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
LORLATINIB (78)
Which INCLISIRAN Alternatives Have Lower Low density lipoprotein increased Risk?
INCLISIRAN vs INCOBOTULINUMTOXINA
INCLISIRAN vs INDACATEROL
INCLISIRAN vs INDAPAMIDE
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL ARGININE